The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1437
March 3, 2014
View Complete Issue         Table of Contents 2019 
Issue 1437
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Testosterone and Cardiovascular Risk
March 3, 2014 (Issue: 1437)
Prompted by the recent publication of 2 retrospective studies, the FDA has announced that it is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.1The first study examined the records of 8709...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1437
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.